Important Announcements

Nondiscrimination Policy Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To read our full Nondiscrimination Statement, click here.

When clinicians across the country are looking to educate and train their teams, they turn to BMC. BMC has developed numerous programs for hospital-based and community-based providers, so that anyone who encounters a patient needing help with addiction can offer them appropriate care. If you’d like to make a request for training or technical support, please email us at Grayken.Center@bmc.org.

Grayken Training and Technical Assistance (Grayken TTA)

The Grayken TTA provides education, support and capacity building to community health centers and other health care and social service providers on best practices caring for patients with substance use disorders, with the goal of expanding access to life-saving treatment.

Learn more about Grayken TTA

Project ECHO: Opioid Addiction Treatment ECHO at BMC

Project ECHO is an innovative tele-mentoring model where expert teams use videoconferencing to conduct virtual clinics on specialty care for community primary care providers. The model provides an opportunity to leverage chronic pain, substance use, and behavioral health expertise to revolutionize medical education, support building capacity in such specialties, and reduce health disparities.

Learn more about Project ECHO

Massachusetts Consultation Services for Treatment of Addiction and Pain (MCSTAP)

MCSTAP supports primary care providers in increasing their capacity for, and comfort in, using evidence-based practices in screening for, diagnosing, treating, and managing the care of all patients with chronic pain and/or substance use disorders. It offers concrete tools, real-time physician consultation, and linkages with community based resources. Providers can reach MCSTAP at 1-833-PAIN-SUD (1-833-724-6783).

Learn more about MCSTAP

MASBIRT TTA

The MASBIRT TTA program trains medical providers, behavioral health providers, public health service providers, and health care support staff to conduct screening, brief intervention, and referral to treatment (SBIRT) services to address the spectrum of unhealthy substance use.

Learn more about MASBIRT TTA

SCOPE of Pain

SCOPE of Pain is a series of continuing medical education/continuing nursing education activities designed to help providers safely and effectively manage patients with chronic pain with opioid analgesics, when appropriate.

Learn more about SCOPE of Pain

Prescribe to Prevent, Naloxone Rescue Kits and Overdose Education

Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists is an online educational program for prescribers, pharmacists, and other health care providers that aims to prevent overdoses among your patients and their social networks. Additionally, naloxone is available at all BMC pharmacies through a standing order; no prescription is necessary.

Learn more about the Prescribe to Prevent program

B SMART

B SMART (Boston Sustainable Models for unhealthy Alcohol use ReducTion) aims to prevent fetal alcohol spectrum disorders and the risks associated with prenatal alcohol exposure. The program offers tailored education and technical assistance on screening, brief intervention, and referral to treatment (SBIRT) for risky alcohol use to Boston HealthNet community health center care teams.

Read more about B SMART

The SAFEST Choice Learning Collaborative

The SBIRT and FASD Education, Support and Treatment (SAFEST) Choice Learning Collaborative aims to reduce the incidence of prenatal alcohol exposure and improve outcomes in children with suspected or diagnosed fetal alcohol spectrum disorders using virtual education for health care teams.

Learn more about the SAFEST CHOICE Learning Collaborative